| Bortezomib |
ENSG00000132832.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000152487.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000152487.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000166770.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000175967.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000177337.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000177738.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000177757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000182057.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000182109.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000182366.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000183535.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000184274.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000188365.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000189149.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000196553.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000197989.9 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000203706.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000203721.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000204241.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000204362.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000204623.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000204706.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000204792.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000204934.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000205041.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000205885.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000205885.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000205890.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000206195.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000213742.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000213793.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000213904.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000213971.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000214559.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000214894.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000215859.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000221817.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000223380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000223401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000223477.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000223695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000223829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000223882.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000223882.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000223946.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000224020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000224063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000224189.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000224490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000224596.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000224621.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000224764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000224812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000224843.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000224844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000224844.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000224846.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000224888.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000225037.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000225075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000225177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000225407.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000225602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000225767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000225790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000225913.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000225945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000225948.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226009.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226089.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000226263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226266.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226328.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000226330.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226381.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000226548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000226648.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000226669.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000226889.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227014.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227036.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000227110.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000227110.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000227165.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000227237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000227256.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227258.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227372.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000227388.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227400.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227438.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000227486.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000227542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000227885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228021.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000228028.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228065.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000228204.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000228242.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000228274.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228288.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000228382.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228397.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228436.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000228540.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000228614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000228649.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000228679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000228763.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228794.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000228838.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000228906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000229109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000229167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000229190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000229463.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000229776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000229931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000230010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000230023.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000230082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000230084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000230084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000230105.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000230534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000230753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000230798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000230826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000230894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000231073.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000231074.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000231355.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000231407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000231621.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000231638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000231724.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000231769.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000231842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000231856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000231865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000231969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000231977.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000231999.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000232043.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000232063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000232104.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232110.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000232233.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000232324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000232445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000232470.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000232721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000232725.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000232756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000232756.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000232762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000232855.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232907.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000232909.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000233006.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233029.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233429.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000233602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233627.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000233693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233783.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000233806.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000233806.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000233825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000233834.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000233852.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000233864.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000233885.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000233926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000234084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000234136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000234183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000234185.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000234264.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000234281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000234323.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000234449.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000234459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000234492.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000234509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000234703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000234771.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000234936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000234978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000234998.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000235066.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000235078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000235096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000235121.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000235123.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000235298.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000235326.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000235373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000235423.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000235586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000235629.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000235772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000235781.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000235781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000235823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000235831.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000235910.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000236144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000236194.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000236299.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000236451.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236472.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000236514.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000236990.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000237015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000237021.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237126.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000237181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000237248.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237328.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000237338.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000237436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000237485.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237491.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000237737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237737.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000237786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000237927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000237998.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000238078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000238164.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000238197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000239002.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000239653.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000239906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000239920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000239920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000240015.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000240137.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000240211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000240453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000240766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000242125.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000242154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000242349.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000243415.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000243701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000244203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000244265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000244268.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000244468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000245080.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000245146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000245275.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000245571.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000245573.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000245598.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000245685.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000245849.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000245857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000246225.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000247137.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000247199.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000247708.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000247844.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000247925.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000248152.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000248223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000248399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000248494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000248668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000248690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000248936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000248968.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000248980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000249417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000249476.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000249502.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000249532.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000249610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000249669.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000249753.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000249791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000249868.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000250012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000250106.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000250159.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000250159.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000250220.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000250240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000250303.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000250320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000250582.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000250734.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000250751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000250842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000250917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000250950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000251095.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000251144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000251417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000251445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000251532.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000251600.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000251661.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000251661.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000251687.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000253230.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000253263.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000253361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253552.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253708.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253736.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000253825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000253829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253853.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253854.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253859.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000253911.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000253948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000253955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000254100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254180.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000254208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254431.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000254459.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254495.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254538.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000254739.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000254821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000254847.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000254990.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000255002.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000255079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255092.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000255139.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000255145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000255234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000255240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255322.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000255328.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000255337.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000255343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000255355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000255449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000255509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000255669.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000255741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000255847.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000255980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000255992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000256196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000256325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000256452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000256603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000256603.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000256967.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000256967.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000256967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000257052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000257151.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000257221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000257298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000257298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000257366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000257391.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000257556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000257563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000257568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000257681.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000257910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000257947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000257964.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000258168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000258279.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000258303.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000258323.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000258354.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000258556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000258658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000258736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000258766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000258851.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000258910.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000258940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000259081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259448.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259499.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259589.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259736.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259767.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000259782.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000259810.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000259867.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000259881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000259972.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260000.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260136.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000260156.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000260194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260369.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000260498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000260630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260633.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260641.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260671.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000260796.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000260884.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000260896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000260929.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000261002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000261019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000261040.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000261055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000261064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000261079.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261094.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261158.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000261360.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000261373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000261396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000261468.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261584.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261644.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000261695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000261731.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000261737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000261760.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000261827.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000261872.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000262001.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000262098.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000262152.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000262179.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000262412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000262663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000262766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000262903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000262973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000263220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000263350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000263370.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000263393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000263466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000263680.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000263766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000263874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000263893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000263916.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000264078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000264188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000264339.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000264577.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000264635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000264666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000264673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000264729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000265094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000265206.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000265451.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000265519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000265556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000265666.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000265743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000265992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000266236.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000266236.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000266237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000266290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000266903.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000266904.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000266936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000266950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000266987.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000267002.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267003.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267044.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267121.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267141.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000267143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000267150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000267194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000267199.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267248.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000267280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000267344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267345.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000267374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267437.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000267454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267479.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000267522.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000267567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000267581.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000267758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000267786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000267798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000268316.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000268364.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000268366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000268471.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000268743.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000268889.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000268889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000269107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000269148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000269290.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000269303.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000269352.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000269392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000269535.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000269646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269656.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000269959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000269997.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000269999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000270031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000270040.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000270048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000270048.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000270061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000270072.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000270091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000270095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000270100.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000270105.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000270462.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000270523.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000270742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000270751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000270761.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000271032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000271347.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000271382.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000271778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000271849.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000271856.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000271971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272053.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000272240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272273.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000272320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272341.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000272368.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000272432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000272446.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000272462.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272508.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272702.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000272735.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000272789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272810.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272810.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000272864.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000272933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000272960.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000273068.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000273076.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000273081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bortezomib |
ENSG00000273084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000273113.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000273123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000273156.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000273186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000273216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000273237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000273249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000273308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000273350.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000273367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
ENSG00000273403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bortezomib |
ENSG00000273448.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bortezomib |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bortezomib |
ENSG00000273488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bortezomib |
hsa-miR-101-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-105-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-106b-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-125a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-130a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-130b-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-142-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-146a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-148a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-149-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-151a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-185-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-188-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-192-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-199b-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-19a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-19b-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-204-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-20b-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-211-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-218-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-23a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-25-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-27a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-30a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-30b-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-30c-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-31-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-338-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-33a-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-345-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-365a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-365b-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-375 |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-378a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-424-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-503-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-506-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-507 |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-508-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-509-3-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-509-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-510 |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-512-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-514a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-551b-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-584-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-590-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-629-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-630 |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-652-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-92a-3p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-93-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
hsa-miR-99b-5p |
predicted miRNA |
NCI60 |
|
| Bortezomib |
miR-101 |
Curated miRNA |
cancer |
|
| Bortezomib |
miR-1202 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-1207 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-122 |
Curated miRNA |
cutaneous T-cell lymphoma |
|
| Bortezomib |
miR-1246 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-125b |
Curated miRNA |
cutaneous T-cell lymphomas |
|
| Bortezomib |
miR-129 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-1290 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-1469 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-149* |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-15a |
Curated miRNA |
myeloma |
|
| Bortezomib |
miR-16 |
Curated miRNA |
myeloma |
|
| Bortezomib |
miR-187 |
Curated miRNA |
peripheral T-cell lymphoma |
|
| Bortezomib |
miR-1908 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-1915 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-192 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-19a |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-202 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-21 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-27a |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-2861 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-29b |
Curated miRNA |
melanoma |
|
| Bortezomib |
miR-29c |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-301a |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-30e |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-3185 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-3196 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-33b |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-638 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-660 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-762 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-92-1 |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-92b |
Curated miRNA |
multiple myeloma |
|
| Bortezomib |
miR-939 |
Curated miRNA |
multiple myeloma |
|
